• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR
Financial results for the full year ended December 31, 2018

Financial results for the full year ended December 31, 2018

by Zina | Mar 20, 2019 | News

READ THE COMPLETE PRESS RELEASE
Financial results for the full year ended December 31, 2018

Mauna Kea Technologies to Announce 2018 Full Year Results on March 20, 2019

by Zina | Mar 15, 2019 | News

READ THE COMPLETE PRESS RELEASE
510(k) Clearance for the Cellvizio® Needle-Based AQ-Flex 19 Confocal Miniprobe Enabling Peripheral Lung Nodule Targeting and Imaging

510(k) Clearance for the Cellvizio® Needle-Based AQ-Flex 19 Confocal Miniprobe Enabling Peripheral Lung Nodule Targeting and Imaging

by Zina | Feb 25, 2019 | News

The Cellvizio® AQ-Flex probe is cleared for use with transbronchial needles through existing bronchoscopes and bronchoscopic accessories Mauna Kea Technologies today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Mauna Kea Technologies Provides An Update On Its Commercial Partnership Agreement For Urological Applications

Mauna Kea Technologies Provides An Update On Its Commercial Partnership Agreement For Urological Applications

by Zina | Feb 21, 2019 | News

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced a mutual decision to terminate the development and distribution agreements with Cook...
Mauna Kea Technologies Reports Fourth Quarter And Full Year 2018 Sales

Mauna Kea Technologies Reports Fourth Quarter And Full Year 2018 Sales

by Zina | Jan 17, 2019 | News

Read the complete press release
« Older Entries
Next Entries »

Articles récents

  • ‘Never a Dull Moment’ Dr. Ravi Prakash Keeps Patients Front and Center
  • Mauna Kea Technologies announces results of its Combined General Meeting of June 5, 2025 
  • Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 
  • Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress 
  • Mauna Kea Technologies announces the availability of preparatory documents for the Combined General Meeting of June 5, 2025 and the instructions for participation 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}